Cambridge Technologies Email Format

Biotechnology ResearchMinnesota, United States51-200 Employees

Cambridge Technologies is an independent, owner-operated biotechnology firm that develops and produces customized vaccines for veterinary use, working with veterinarians and livestock producers to address emerging animal health problems. The company manages the full vaccine development cycle in-house, leveraging diagnostic and manufacturing capabilities to identify appropriate isolates and translate them into vaccines. 

Production takes place at a USDA-licensed facility in Worthington, Minnesota, a 37,000-square-foot site with a modern fermentation suite. Vaccines are customized to customer needs through tailored formulations and labeling options. In April 2024 Cambridge Technologies announced a partnership with Merck Animal Health USA to provide autogenous poultry vaccines in the United States.

Sign up for free to view info

Company overview Employee directory